We report two patients with severe congenital factor V deficiency, one of w
hom also had a factor V inhibitor, who required correction of their coagulo
pathy prior to surgical procedures. They underwent plasma exchange (PE) wit
h fresh frozen plasma or solvent/detergent treated plasma (S/DP), with achi
evement of factor V levels satisfactory for hemostasis for their procedures
. PE makes it possible to raise factor levels quickly and sufficiently with
out volume overload. In addition, transient reduction of inhibitor titers b
y PE may improve the level of correction achievable during the perioperativ
e period. The advent of S/DP promises to provide an added increment of safe
ty in patients exposed to significant volumes of plasma during PE. (C) 2001
Wiley-Liss, Inc.